Table 2

Parameter estimates for the final population model: Ka (h−1) = θ1, Cl/F (L/h) = (θ2*W+θ3*D)*(1−θ4*IDF), Vd/F (L) = (θ5*W+θ6*D)*(1+θ7*FS)

ParameterEstimateSE (%)*95% CI
W, body weight; D, dose; θ, population specific pharmacokinetic parameter; IDF, ibuprofen dosage form (ibuprofen lysinate = 0/ibuprofen free acid = 1); FS, fasting status (fasting = 0/food = 1).
*Standard error of the estimate expressed as coefficient of variation (%).
†For a mean concentration of 38 mg/l.
θ16.6631.472.52 to 10.80
θ20.0713.700.05 to 0.09
θ30.0820.840.05 to 0.11
θ40.2822.060.16 to 0.41
θ50.1018.980.06 to 0.16
θ60.0644.410.01 to 0.12
θ70.3745.342.52 to 10.80
Interindividual variability: ω2Cl/F: 75% (CV); ω2Vd/F: 45% (CV)
Residual variability: σ2: ±6.74 mg/l (CV = 18%)†